Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,276.00
Bid: 2,274.00
Ask: 2,278.00
Change: 58.00 (2.61%)
Spread: 4.00 (0.176%)
Open: 2,212.00
High: 2,280.00
Low: 2,212.00
Prev. Close: 2,218.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 2018 Business Update

10 May 2018 07:00

RNS Number : 5772N
Derwent London PLC
10 May 2018
 

10 May 2018

 

Derwent London plc ("Derwent London" / "the Group")

FIRST QUARTER BUSINESS UPDATEGOOD OCCUPIER DEMAND CONTINUES

Highlights

· Occupier interest remains good with 164,500 sq ft of lettings signed or under offer:

o 51,500 sq ft new lettings achieving £2.4m of rents, 4.9% above December 2017 ERV

o 113,000 sq ft under offer for c.£7.2m of rents

· Two developments under construction totalling 623,000 sq ft, 45% pre-let:

o 80 Charlotte Street W1, 86% of the office space pre-let

o Brunel Building W2, 32% under offer

· Preliminary work started at Soho Place W1, 285,000 sq ft

· Two refurbishments completed totalling 77,100 sq ft and taking the EPRA vacancy rate to 4.1%

· Disposal of Porters North N1 for £48.5m (our 50% interest £24.3m), above December 2017 value

· LTV ratio 13.2% at 31 March 2018, with cash and undrawn facilities of £514m

 

John Burns, Chief Executive, commented:

"We continue to make good progress with our developments. Occupier interest remains encouraging and we have a significant amount of space under offer."

 

Webcast and conference call

There will be a live webcast together with a conference call for investors and analysts at 09:00 BST today. The audio webcast can be accessed via www.derwentlondon.com

To participate in the call, please dial the following number: +44 (0)20 3059 5868.

A recording of the conference call will also be made available following the conclusion of the call on www.derwentlondon.com

 

For further information, please contact:

Derwent London

Tel: +44 (0)20 7659 3000

 

 

John Burns, Chief Executive

Damian Wisniewski, Finance Director

Quentin Freeman, Head of Investor Relations

 

Brunswick Group

Tel: +44 (0)20 7404 5959

 

Simon Sporborg

Nina Coad

Emily Trapnell

 

 

Letting activity

Having de-risked a substantial part of our development programme last year we have achieved a further £2.4m of new lettings year to date which, on average, have been 4.9% above December 2017 ERV.

We have also completed the refurbishments at Johnson Building EC1 and 25 Savile Row W1 which were the major contributors to the increase in the EPRA vacancy rate to 4.1%. Together they represent more than half the vacant space.

We are seeing good occupier interest and currently have 113,000 sq ft under offer including our first potential letting at Brunel Building W2. If all these transactions complete, they will produce a further c.£7.2m of new rents.

Development progress (see Appendix)

We have two on-site developments. As already announced 80 Charlotte Street W1 is 73% pre-let, or 86% based on the offices alone. There is strong interest in the Brunel Building where 32% is under offer. In January Crossrail handed over the site of Soho Place W1 enabling us to begin preliminary work.

Disposal

In March Porters North N1 was sold for £48.5m, or £43.0m net of rental top-ups, disposal costs and a capital contribution to the tenant. The 44,100 sq ft building was held in a 50:50 joint venture and was sold at a 5% premium to December 2017 book value.

Finance

Capital expenditure and properties acquired in the first three months of 2018 totalled £53.1m including £2.4m of capitalised interest. There were no significant property acquisitions and the only disposal in the period was Porters North; at the sale date, the associated £13.5m of bank debt (Group share: £6.8m) was repaid.

Group net debt rose marginally during the quarter ended 31 March 2018 to £667.5m giving an unchanged loan-to-value ratio of 13.2% based on December 2017 property valuations, and interest cover rose again to 519%. The weighted average interest rate was 3.77% on a cash basis and 4.08% on an IFRS basis. Undrawn facilities and cash were largely unchanged at £514m and the weighted average debt maturity was 7.3 years.

Subject to shareholder approval, the 2017 final dividend of 42.4p per share and the special dividend of 75.0p per share will be paid to shareholders on 8 June 2018, the shares having become ex-dividend on 3 May. These dividends have given rise to an adjustment to the conversion price of the Group's £150m 1.125% convertible bonds due July 2019 from £32.7342 per share to £31.7764.

Property values

Central London office values remain firm. MSCI IPD is reporting capital growth of 0.4% in the first quarter of 2018 with rents falling marginally by 0.2%.

 

Appendix: Major developments pipeline

 

Property

Areasq ft

Capex to complete

£m1

Comment

On-site projects

Brunel Building, 2 Canalside Walk W2

243,000

70

Offices - 32% under offer

80 Charlotte Street W1

380,000

182

321,000 sq ft offices, 45,000 sq ft residential and 14,000 sq ft retail - 73% pre-let overall

 

623,000

252

Other major planning consents

Soho Place W1

285,000

209,000 sq ft offices, 36,000 sq ft retail and 40,000 sq ft theatre

 

Monmouth House EC1

125,000

Offices, workspaces and retail

19-35 Baker Street W12

293,0003

206,000 sq ft offices, 52,000 sq ft residential and 35,000 sq ft retail

Holden House W12

150,000

Retail flagship or retail and office scheme

853,000

Grand total

1,476,000

 

1 As at 31 Dec 2017 2 Resolution to grant planning permission obtained 3 Total area - Derwent London has a 55% share of the joint venture

 

 

 

Notes to editors

 

Derwent London plc

 

Derwent London plc owns 87 buildings in a commercial real estate portfolio predominantly in central London valued at £4.9 billion (including joint ventures) as at 31 December 2017, making it the largest London-focused real estate investment trust (REIT).

 

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

 

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

 

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

 

Landmark schemes in our 5.5 million sq ft portfolio include White Collar Factory EC1, Angel Building EC1, The Buckley Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

 

In 2018 to date the Group has won the Property Week Property Company of the Year award whilst White Collar Factory scooped two BCO awards for Commercial Workplace and Innovation. In 2017 the Group collected the Property Week Developer of the Year award and EG Offices Company of the Year and won further awards from RIBA, Civic Trust and BCO. In 2013 Derwent London launched a voluntary Community Fund and has to date supported 56 community projects in Fitzrovia and the Tech Belt.

 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

Forward-looking statements

 

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

 

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKONRWAAVRAR
Date   Source Headline
28th Feb 20237:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
31st Jan 202311:30 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSDirector Declaration
20th Jan 20232:50 pmRNSHolding(s) in Company
19th Jan 20232:30 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSSale of 19 Charterhouse Street EC1
30th Dec 20221:15 pmRNSTotal Voting Rights
6th Dec 20224:00 pmRNSHolding(s) in Company
30th Nov 20224:30 pmRNSTotal Voting Rights
16th Nov 202212:15 pmRNSHolding(s) in Company
3rd Nov 20227:00 amRNSThird Quarter Business Update
31st Oct 20224:45 pmRNSTotal Voting Rights
19th Oct 20223:31 pmRNSDirector/PDMR Shareholding
13th Oct 20225:20 pmRNSHolding(s) in Company
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:45 pmRNSTotal Voting Rights
21st Sep 20225:00 pmRNSDirector/PDMR Shareholding
20th Sep 20224:30 pmRNSBlock listing Interim Review
31st Aug 20224:45 pmRNSTotal Voting Rights
25th Aug 20229:15 amRNSAdditional Listing
17th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202210:30 amRNSHolding(s) in Company
11th Aug 20227:00 amRNSUnaudited Results for six months ended 30.06.22
10th Aug 20224:30 pmRNSHolding(s) in Company
2nd Aug 20223:45 pmRNSHolding(s) in Company
29th Jul 20224:45 pmRNSTotal Voting Rights
26th Jul 20225:15 pmRNSHolding(s) in Company
21st Jul 20223:00 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSDisposal of Bush House WC2
30th Jun 20224:45 pmRNSTotal Voting Rights
9th Jun 202210:00 amRNSAdditional Listing
6th Jun 20222:00 pmRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSTotal Voting Rights
26th May 20223:10 pmRNSHolding(s) in Company
24th May 20225:10 pmRNSHolding(s) in Company
13th May 20221:00 pmRNSResult of AGM
10th May 20229:00 amRNSBondholders' Meeting
5th May 20227:01 amRNSCity Road Island EC1 Exchange of Contract
5th May 20227:00 amRNSQ1 2022 Business Update
29th Apr 20224:45 pmRNSTotal Voting Rights
13th Apr 20222:00 pmRNSReport and Accounts 2021 and Notice of AGM
31st Mar 20224:45 pmRNSTotal Voting Rights
22nd Mar 20229:00 amRNSBlock listing Interim Review replacement
21st Mar 20226:10 pmRNSBlock listing Interim Review
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
10th Mar 20222:00 pmRNSDirector/PDMR Shareholding
10th Mar 202210:00 amRNSAdditional Listing
2nd Mar 20229:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.